Clinical Trial Update: Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update comparing lenvatinib plus everolimus or lenvatinib plus pembrolizumab versus sunitinib alone in advanced renal cell carcinoma; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Everolimus (everolimus)
• Lenvatinib (lenvatinib)
• Pembrolizumab (pembrolizumab)
• Sunitinib (sunitinib)

Snippet

Sponsor: Eisai Inc. | Conditions: Renal Cell Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2021-09-24